Feasibility of cardiopulmonary exercise testing in interstitial lung disease: the PETFIB study
Introduction Cardiopulmonary exercise testing (CPET) provides a series of biomarkers, such as peak oxygen uptake, which could assess the development of disease status in interstitial lung disease (ILD). However, despite use in research and clinical settings, the feasibility of CPET in this patient g...
Main Authors: | Michael Gibbons, Alexander Spiers, Craig Williams, Owen Tomlinson, Anna Duckworth, Laura Markham, Rebecca Wollerton, Bridget Knight, Chris Scotton |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-08-01
|
Series: | BMJ Open Respiratory Research |
Online Access: | https://bmjopenrespres.bmj.com/content/8/1/e000793.full |
Similar Items
-
Cardiopulmonary Exercise Testing in Patients With Interstitial Lung Disease
by: Yannick Molgat-Seon, et al.
Published: (2020-07-01) -
Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing
by: Matteo Bonini, et al.
Published: (2017-02-01) -
The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review
by: Shaney L. Barratt, et al.
Published: (2020-08-01) -
Cardiopulmonary responses to maximal aerobic exercise in patients with cystic fibrosis.
by: Craig A Williams, et al.
Published: (2019-01-01) -
Cardiopulmonary exercise testing in the clinical evaluation of patients with interstitial lung disease: A systematic review
by: Abdullah Rashed Alharbi
Published: (2021-01-01)